Nasdaq:US$13.81 (+0.07) | HKEX:HK$21.95 (-0.15) | AIM:£2.27 (-0.06)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility

1 items
a070618